Literature DB >> 29178052

Prospect of Using Cell Product for the Therapy of Skin Defects in Diabetes Mellitus.

A P Lykov1,2, N A Bondarenko3,4, O V Poveshchenko3,4, T V Miller3, A F Poveshchenko3,4, M A Surovtseva3,4, N P Bgatova3, V I Konenkov3.   

Abstract

The effectiveness of autologous cell product in the therapy of skin burn wounds was studied in C57B1/6 male mice against the background of streptozotocin-induced diabetes mellitus. In animals with and without modeled diabetes mellitus, significant decrease in skin defect area was observed after single administration of the cell product (bone marrow multipotent mesenchymal stromal cells, fibroblasts or media conditioned by these cells).

Entities:  

Keywords:  bone marrow multipotent mesenchymal stromal cells; cell product; conditioned media; streptozotocin-induced diabetes

Mesh:

Substances:

Year:  2017        PMID: 29178052     DOI: 10.1007/s10517-017-3970-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Activation of TLR4 of Mesenchymal Stem Cells Enhances the Regenerative Properties of Their Secretomes.

Authors:  A L Rusanov; Yu K Biryukova; O O Shoshina; E D Luzgina; N G Luzgina
Journal:  Bull Exp Biol Med       Date:  2021-03-16       Impact factor: 0.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.